韩靖远,冯晨曦,陈 琼,等.2020年河南省食管癌流行现况及2010—2020年变化趋势分析[J].中国肿瘤,2024,33(10):841-848.
2020年河南省食管癌流行现况及2010—2020年变化趋势分析
Incidence and Mortality of Esophageal Cancer in Henan in 2020 and Trends from 2010 to 2020
投稿时间:2024-07-30  
DOI:10.11735/j.issn.1004-0242.2024.10.A010
中文关键词:  食管癌  发病率  死亡率  趋势  河南
英文关键词:esophageal cancer  incidence  mortality  trend  Henan
基金项目:国家重点研发计划政府间国际科技创新合作重点专项(2021YFE0106000)
作者单位
韩靖远 郑州大学附属肿瘤医院/河南省肿瘤医院/河南省肿瘤防控工程研究中心/河南省肿瘤预防国际联合实验室 
冯晨曦 郑州大学附属肿瘤医院/河南省肿瘤医院/河南省肿瘤防控工程研究中心/河南省肿瘤预防国际联合实验室 
陈 琼 郑州大学附属肿瘤医院/河南省肿瘤医院/河南省肿瘤防控工程研究中心/河南省肿瘤预防国际联合实验室 
徐慧芳 郑州大学附属肿瘤医院/河南省肿瘤医院/河南省肿瘤防控工程研究中心/河南省肿瘤预防国际联合实验室 
摘要点击次数: 339
全文下载次数: 114
中文摘要:
      摘 要:[目的]分析2020年河南省食管癌发病和死亡情况及2010—2020年变化趋势。[方法] 基于河南省各肿瘤登记处上报的符合质量标准的数据,以性别和城乡为分层依据,分别计算2020年食管癌粗发病/死亡率、中国人口标化发病/死亡率(简标中标率)和世界人口标化发病/死亡率(简称世标率)。利用Joinpoint软件计算年度变化百分比(annual percentage change,APC)和平均年度变化百分比(average annual percentage change,AAPC),分析2010—2020年食管癌发病与死亡的变化趋势。[结果] 据估计,2020年河南省食管癌新发病例26 700例,粗发病率为24.38/10万,中标率为17.50/10万,世标率为17.60/10万;2020年河南省估计食管癌死亡病例数为20 988例,粗死亡率为19.16/10万,中标率为13.14/10万,世标率为13.08/10万。农村地区中标发病率是城市地区的1.79倍、中标死亡率是城市地区的1.68倍。男性中标发病率是女性的1.81倍、中标死亡率是女性的2.01倍。年龄别发病率和年龄别死亡率均是40岁开始迅速上升,均在85岁及以上年龄组达峰值。2010—2020年河南省食管癌中标发病率和中标死亡率总体呈显著下降趋势(AAPC分别为-5.70%和-4.73%,P均<0.05)。[结论] 河南省食管癌疾病负担较为严重,呈现性别差异和城乡差异。近10年河南省发病率和死亡率呈显著下降趋势,但仍然高于全国平均水平。
英文摘要:
      Abstract: [Purpose] To estimate the incidence and mortality of esophageal cancer in Henan Province in 2020 and the trends from 2010 to 2020. [Methods] Based on data reported by cancer registries in Henan Province, the crude incidence and mortality rates, age-standardized incidence and mortality rates by Chinese and world standard population (ASIRC/ASIRW, ASMRC/ASMRW) for esophageal cancer in 2020 were calculated, and stratified by gender and urban-rural areas. Joinpoint software was used to calculate the annual percentage change(APC) and average annual percentage change(AAPC) to analyze trends in esophageal cancer incidence and mortality from 2010 to 2020. [Results] It was estimated that there were 26 700 new cases of esophageal cancer in Henan Province in 2020 with a crude incidence rate of 24.38/105, an ASIRC of 17.50/105 and ASIRW of 17.60/105. The estimated number of esophageal cancer deaths in Henan Province in 2020 was 20 988, with a crude mortality rate of 19.16/105, an ASMRC of 13.14/105 and ASMRW of 13.08/105. The ASIRC in rural areas was 1.79 times as high as that of urban areas, while the ASMRC was 1.68 times as high. The ASIRC for males was 1.81 times as high as that of females, and the ASMRC rate was 2.01 times as high. Both age-specific incidence and mortality rates rose rapidly from age 40, reaching the peak in the age group of above 85 years old. From 2010 to 2020, the ASIRC and ASMRC of esophageal cancer showed a significant overall downward trend (AAPC of -5.70% and -4.73%, respectively, both P<0.05). [Conclusion] The disease burden of esophageal cancer in Henan Province is relatively severe, showing gender and urban-rural disparities. The incidence and mortality rates show a significant downward trend from 2010 to 2020, but they still remain higher than the national average.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器